DIMENSION LIDOCAINE (LIDO) FLEX REAGENT CARTRIDGE METHOD, DIMENSION DRUG CALIBRATOR II, MODELS DF113. DC49D

Enzyme Immunoassay, Lidocaine

DADE BEHRING, INC.

The following data is part of a premarket notification filed by Dade Behring, Inc. with the FDA for Dimension Lidocaine (lido) Flex Reagent Cartridge Method, Dimension Drug Calibrator Ii, Models Df113. Dc49d.

Pre-market Notification Details

Device IDK033809
510k NumberK033809
Device Name:DIMENSION LIDOCAINE (LIDO) FLEX REAGENT CARTRIDGE METHOD, DIMENSION DRUG CALIBRATOR II, MODELS DF113. DC49D
ClassificationEnzyme Immunoassay, Lidocaine
Applicant DADE BEHRING, INC. GLASGOW BUSINESS COMMUNITY; BLDG. 500 MAIL BOX 514 P.o. Box 6101, Newark,  DE  19714 -6101
ContactRichard M Vaught
CorrespondentRichard M Vaught
DADE BEHRING, INC. GLASGOW BUSINESS COMMUNITY; BLDG. 500 MAIL BOX 514 P.o. Box 6101, Newark,  DE  19714 -6101
Product CodeKLR  
CFR Regulation Number862.3555 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2003-12-08
Decision Date2004-02-20
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00630414220680 K033809 000
00842768005305 K033809 000
00842768005176 K033809 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.